Oct. 7, 2024 — Doctors have long believed the cancer drug 5-fluorouracil works by damaging the building blocks of DNA, but researchers have now found that in certain cancers, it kills cells by ...

Erythropoiesis-stimulating agents (ESAs) are capable of increasing hemoglobin levels in most anemic patients with cancer. Using ESAs to treat anemia in cancer patients reduces transfusion ...

For cancer patients, anemia can be a debilitating problem that negatively influences their overall quality of life and worsens their prognosis. The condition is caused either by the cancer itself ...

More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

13, 2024 — Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers. The investigational mRNA cancer ...

What reduces your stress and relaxes your body and spirit, Cancer? With the Sagittarius moon in your sixth house of work and wellbeing, you’re reminded that your productivity hinges on your self ...

Back at square one? As the moon and Saturn clash, you’re putting in work, but results are slow to show. This is all part of the growth process. You’re on the right track, but don’t expect ...

This Facts & Figures report provides statistics about the occurrence of breast cancer as well as about its risk factors, prevention, early detection, and treatment. For a short summary, see the news ...

Whether you or a loved one are worried about developing breast cancer, have just been diagnosed, are going through breast cancer treatment, or are trying to stay well after treatment, this detailed ...

Allicin can have an effect on cells called signaling cells, which control cell growth. When looking at the potential benefits of garlic in relation to cancer prevention, it's helpful to search for ...

Roche revealed in its first-quarter results statement that giredestrant missed the mark in the phase 2 acelERA trial in advanced breast cancer ... but pharma also had a solid start to the year ...